Celgene invested $30M in NantCell weeks before BMS bid

NantCell said Celgene Corp. (NASDAQ:CELG) invested $30 million through a crossover round, valuing NantCell at $4

Read the full 160 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE